Neuroendocrine differentiation in cervical carcinoma

被引:25
|
作者
Savargaonkar, PR
Hale, RJ
Mutton, A
Manning, V
Buckley, CH
机构
[1] STEPPING HILL HOSP,DEPT PATHOL,STOCKPORT,CHESHIRE,ENGLAND
[2] ST MARYS HOSP,DEPT REPROD PATHOL,MANCHESTER M13 0JH,LANCS,ENGLAND
[3] N MANCHESTER GRP HOSP,MANCHESTER,LANCS,ENGLAND
关键词
neuroendocrine tumours; chromogranin A; cervical carcinoma;
D O I
10.1136/jcp.49.2.139
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To examine neuroendocrine differentiation, as shown by chromogranin A (CGA) expression, in cervical carcinomas. Methods-Sixty seven cervical carcinomas were studied and were classified as adenocarcinomas, adenosquamous carcinomas or squamous cell carcinomas based on the assessment of haematoxylin and eosin staining and stains for mucin. Where features of glandular differentiation were identified, sections were also stained for evidence of intestinal type mucin. CGA immunostaining was done and the results were graded on a three point scale: 0, + (1-5% of cells positive) and + + (>5% of cells positive). These findings were then analysed with respect to lymph node status, tumour differentiation and clinical outcome. Results-There were 32 adenocarcinomas, 18 adenosquamous carcinomas and 17 squamous cell carcinomas. Positive staining was seen in 14 (20.9%) cases, of which four were strongly positive. All but one case were either adenocarcinomas or adenosquamous carcinomas. There was a trend for CGA positivity to be related to intestinal differentiation but this failed to reach statistical significance. No correlation could be demonstrated between CGA staining and lymph node status, tumour differentiation and clinical outcome. Conclusions Neuroendocrine differentiation is common in cervical carcinomas where there is evidence of glandular differentiation. Whilst the numbers in this study are relatively small, the presence of neuroendocrine cells in otherwise typical carcinomas does not seem to have any association with clinical behaviour.
引用
收藏
页码:139 / 141
页数:3
相关论文
共 50 条
  • [1] Cervical Carcinoma With Divergent Neuroendocrine and Gastrointestinal Differentiation
    Varma, Kavita R.
    Dabbs, David J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2018, 37 (05) : 488 - 491
  • [2] Neuroendocrine differentiation in a case of cervical cancer
    Rashed, Mona Mohamed
    Bekele, Alemayehu
    PAN AFRICAN MEDICAL JOURNAL, 2010, 6
  • [3] Neuroendocrine differentiation in prostatic carcinoma
    Hansson, J
    Abrahamsson, PA
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2003, 37 : 28 - 36
  • [4] Trichilemmal carcinoma with neuroendocrine differentiation
    Pozo, L.
    Diaz-Cano, S. J.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2008, 33 (02) : 128 - 131
  • [5] Apocrine carcinoma with neuroendocrine differentiation
    Imamura, Taichi
    Kuwahara, Fumi
    Saruta, Hiroshi
    Nakama, Takekuni
    Ohata, Chika
    JOURNAL OF CUTANEOUS PATHOLOGY, 2017, 44 (09) : 810 - 812
  • [6] NEUROENDOCRINE DIFFERENTIATION IN PROSTATIC CARCINOMA
    Abrahamsson, Per-Anders
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3415 - 3417
  • [7] Neuroendocrine differentiation in prostatic carcinoma
    Abrahamsson, PA
    PROSTATE, 1999, 39 (02): : 135 - 148
  • [8] Neuroendocrine differentiation in eccrine carcinoma
    Rahilly, M
    Lessels, AM
    Beattie, GJ
    HISTOPATHOLOGY, 1996, 29 (04) : 390 - 390
  • [9] Neuroendocrine differentiation in non-neuroendocrine thyroid carcinoma
    Kargi, A
    Yorukoglu, K
    Aktas, S
    Cakalagaoglu, F
    Ermete, M
    THYROID, 1996, 6 (03) : 207 - 210
  • [10] Neuroendocrine differentiation in prostatic carcinoma: An update
    di Sant'Agnese, PA
    PROSTATE, 1998, : 74 - 79